Navigation Links
Drug to Prevent Preterm Labor Shows Little Benefit
Date:11/26/2008

No difference found between intensive nifedipine therapy and placebo, researchers say

WEDNESDAY, Nov. 26 (HealthDay News) -- A muscle relaxant drug widely used to prevent premature birth when women go into early labor is no more effective than a placebo at maintaining pregnancy, after the initial spell of preterm labor is stopped.

So say U.S. researchers who conducted the first ever placebo-controlled test of nifedipine and its effect on premature delivery with prolonged treatment. The study included 71 women who'd been successfully treated for preterm labor between 24 and 34 weeks of pregnancy. The women were randomly assigned to receive either nifedipine or placebo every six hours until 37 weeks of pregnancy or delivery, whichever came first.

The team found no differences between the two groups of women in terms of whether their pregnancies lasted until 37 weeks; of how long delivery was delayed; or in their babies' gestational age, birth weight and complications of prematurity. About 40 percent of women in both groups reached 37 weeks of pregnancy, with delivery delayed an average of one month.

The study is published in the December issue of the journal Obstetrics & Gynecology.

"Medication use should be minimized in pregnancy unless it's clearly indicated," lead author Dr. Deirdre Lyell, an assistant professor of obstetrics and gynecology at Stanford University School of Medicine, noted in a school news release.

Serious side effects are rare in pregnant women treated with nifedipine, she said, but even a low risk isn't worthwhile if a drug provides no benefit.

"We all want to prevent preterm birth, but prolonged treatment with nifedipine doesn't appear to be the answer," said Lyell, who believes a larger study of nifedipine is warranted.

More information

The U.S. National Institute of Child Health and Human Development has more about preterm labor and birth.



-- Robert Preidt



SOURCE: Stanford University, news release, Nov. 25, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Stanford/Packard study shows no benefit from drug widely used to prevent premature births
2. Drug Abuse and Violence Prevention Program Generates $16 Million in Potential Savings
3. US$18.5 million grant makes male circumcision a top-tier HIV prevention strategy
4. The 5-Percent Plan: Preventing Diabetes and Heart Disease
5. Heartworm Disease Prevention Protects Pets, Wallets
6. Robert Wood Johnson Foundation Announces Grant Recipients for $18 Million Dollar Initiative to Prevent Intimate Partner Violence
7. Ginkgo Biloba for Prevention of Dementia
8. Stay Upbeat, Exercise to Help Prevent Cancer in Old Age
9. Indoor Allergy Week - Cleanaer™, the New Air Purifier that Helps Prevent Spread of the Common Cold While Removing Airborne Allergen
10. Vitamin C, E Supplements Wont Help Prevent Cancer
11. Early Life Peanut Consumption Might Prevent Allergy
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Drug to Prevent Preterm Labor Shows Little Benefit
(Date:3/24/2017)... ... ... The Radiology Business Management Association (RBMA) has named the nine winners ... year, are among the most prestigious in radiology marketing because a panel of radiology ... recognize achievements in both large budget (over $5,000) and small budget (under $5,000) campaigns. ...
(Date:3/24/2017)... ... ... The iaedp Foundation, the premier provider of educational programs and training standards ... full spectrum of disordered eating, announced today that the 2017 Symposium set a new ... and several countries converged on the Green Valley Resort in Las Vegas. , ...
(Date:3/24/2017)... Calif. (PRWEB) , ... March 24, 2017 , ... ... raised over $100,000 for its innovative EcoQube Frame vertical micro-veggies garden on ... instant demand for the product – with nearly 2,000 consumers (and counting) already ...
(Date:3/24/2017)... ... March 24, 2017 , ... ... at the Advanced ERISA Benefit Claims Litigation seminar in Chicago, Illinois. She ... Record, The majority of cases litigated under ERISA involve claims for long-term disability ...
(Date:3/24/2017)... ... March 24, 2017 , ... Gastro Health ... partnership to prep patients for colonoscopy at the HyGIeaCare® Center that is to ... Miami, FL. , The HyGIeaCare® Prep, cleared by the U.S. Food ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... March 27, 2017  PhaseRx, Inc. (NASDAQ: PZRX), ... inherited liver diseases in children, today reported financial ... ended December 31, 2016 and provided an update ... continued to make progress during the fourth quarter ... from our non-human primate safety study, and with our ...
(Date:3/27/2017)... HAMILTON, N.J. , March 27, 2017 ... company and leading in vivo pharmacology contract ... Solar Farm adjacent to its newly expanded preclinical research ... The solar farm provides a cleaner, renewable energy source ... on the environment. Completion of the Genesis Solar Farm ...
(Date:3/24/2017)... , March 24, 2017 According to a new report ... and Industry Forecast, 2014-2022," the spine bone stimulators market was valued at $562 ... at a CAGR of 3.6% during the forecast period. ... ... Research Logo ...
Breaking Medicine Technology: